Index S&P 500
P/E 29.42
EPS (ttm) 3.16
Insider Own 0.12%
Shs Outstand 821.41M
Perf Week 2.05%
Market Cap 76.20B
Forward P/E 24.20
EPS next Y 3.84
Insider Trans -28.25%
Shs Float 819.49M
Perf Month 6.27%
Income 2.61B
PEG 3.49
EPS next Q 0.87
Inst Own 85.47%
Short Float 1.15%
Perf Quarter 9.76%
Sales 19.75B
P/S 3.86
EPS this Y 9.01%
Inst Trans -0.61%
Short Ratio 2.16
Perf Half Y 23.96%
Book/sh 0.28
P/B 331.31
EPS next Y 8.99%
ROA 15.95%
Short Interest 9.42M
Perf Year 14.30%
Cash/sh 1.60
P/C 58.17
EPS next 5Y 8.44%
ROE 2331.25%
52W Range 67.62 - 93.25
Perf YTD 16.52%
Dividend Est. 2.01 (2.17%)
P/FCF 25.21
EPS past 5Y 0.18%
ROI 31.15%
52W High -0.39%
Beta 0.39
Dividend TTM 1.94 (2.09%)
Quick Ratio 0.70
Sales past 5Y 4.62%
Gross Margin 59.00%
52W Low 37.36%
ATR (14) 1.33
Dividend Ex-Date Jan 19, 2024
Current Ratio 1.06
EPS Y/Y TTM 65.39%
Oper. Margin 22.28%
RSI (14) 76.17
Volatility 1.74% 1.39%
Employees 34000
Debt/Eq 37.78
Sales Y/Y TTM 7.71%
Profit Margin 13.22%
Recom 1.83
Target Price 96.71
Option/Short Yes / Yes
LT Debt/Eq 35.44
EPS Q/Q 85.18%
Payout 68.86%
Rel Volume 1.24
Prev Close 92.91
Sales Surprise 2.12%
EPS Surprise 5.81%
Sales Q/Q 6.18%
Earnings Apr 26 BMO
Avg Volume 4.37M
Price 92.88
SMA20 5.07%
SMA50 5.38%
SMA200 16.83%
Trades
Volume 5,432,689
Change -0.03%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Resumed
Goldman
Buy
$93
Jan-29-24 Upgrade
Raymond James
Mkt Perform → Outperform
Dec-15-23 Upgrade
BofA Securities
Neutral → Buy
$90
Nov-13-23 Initiated
Jefferies
Buy
$87
Oct-16-23 Upgrade
Stifel
Hold → Buy
$85 → $81
Sep-22-23 Initiated
HSBC Securities
Buy
$84
Feb-17-23 Initiated
Citigroup
Buy
$84
Jan-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$82
Nov-22-22 Initiated
Wolfe Research
Peer Perform
Oct-13-22 Upgrade
JP Morgan
Neutral → Overweight
$79
Aug-01-22 Upgrade
Wells Fargo
Underweight → Equal Weight
$71 → $80
May-03-22 Downgrade
Atlantic Equities
Overweight → Neutral
$92 → $80
Apr-08-22 Initiated
Raymond James
Mkt Perform
Feb-02-22 Upgrade
Bernstein
Underperform → Mkt Perform
$83
Jan-31-22 Reiterated
Wells Fargo
Underweight
$78 → $76
Jan-31-22 Reiterated
Morgan Stanley
Equal-Weight
$90 → $91
Jan-31-22 Reiterated
Deutsche Bank
Buy
$91 → $90
Jan-31-22 Reiterated
Credit Suisse
Outperform
$95 → $90
Jan-31-22 Reiterated
Citigroup
Neutral
$83 → $86
Dec-16-21 Initiated
Redburn
Neutral
Show Previous Ratings
May-03-24 04:07PM
11:02AM
09:40AM
May-01-24 01:41PM
(Investor's Business Daily)
12:09PM
12:45PM
Loading…
Apr-30-24 12:45PM
09:50AM
08:29AM
08:10AM
06:10AM
Apr-29-24 01:10PM
12:28PM
09:39AM
09:35AM
09:24AM
09:15AM
Loading…
09:15AM
08:25AM
08:25AM
07:57AM
07:16AM
06:54AM
06:46AM
Apr-28-24 06:54PM
06:49PM
Apr-27-24 01:01AM
Apr-26-24 10:39PM
(Thomson Reuters StreetEvents)
03:00PM
11:53AM
11:46AM
11:08AM
10:33AM
Loading…
10:33AM
09:32AM
09:30AM
07:42AM
07:25AM
07:04AM
07:02AM
(Associated Press Finance)
07:00AM
06:55AM
06:00AM
Apr-25-24 03:00AM
Apr-24-24 03:02AM
Apr-23-24 02:32PM
12:25PM
09:15AM
07:30AM
Apr-21-24 10:44AM
07:22AM
07:00AM
Apr-19-24 10:00AM
Apr-18-24 08:15AM
07:02AM
Apr-17-24 06:15PM
Apr-16-24 03:02AM
Apr-15-24 07:41AM
Apr-12-24 09:35AM
Apr-11-24 07:37PM
Apr-10-24 12:10PM
Apr-09-24 07:13AM
Apr-05-24 08:48AM
Apr-04-24 09:00AM
Apr-03-24 02:24PM
11:45AM
Apr-02-24 04:12PM
Apr-01-24 09:40AM
Mar-31-24 11:47AM
11:41AM
Mar-30-24 07:34AM
Mar-29-24 12:16PM
Mar-28-24 01:38PM
11:21AM
Mar-27-24 05:04AM
Mar-21-24 10:09AM
Mar-19-24 03:43PM
09:33AM
Mar-18-24 11:45AM
Mar-14-24 04:35PM
Mar-13-24 11:30AM
Mar-12-24 01:08PM
10:43AM
Mar-05-24 04:17PM
Mar-04-24 06:25PM
Mar-01-24 11:35AM
Feb-28-24 09:35AM
04:41AM
Feb-27-24 07:00AM
Feb-26-24 03:33PM
08:07AM
Feb-21-24 02:43PM
(Investor's Business Daily)
Feb-16-24 12:03AM
Feb-15-24 04:30PM
Feb-14-24 11:45AM
Feb-13-24 11:49AM
09:50AM
Feb-12-24 02:02AM
Feb-07-24 09:30AM
Jan-31-24 02:32PM
01:44PM
12:16PM
Jan-30-24 10:46AM
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Massey Sally Chief Human Resources Officer May 01 '24 Option Exercise 72.29 6,115 442,053 20,039 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Option Exercise 62.04 6,329 392,651 36,565 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Sale 91.59 6,329 579,696 30,236 May 03 04:04 PM Massey Sally Chief Human Resources Officer May 01 '24 Sale 91.92 6,115 562,091 13,924 May 03 04:04 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Option Exercise 68.16 55,486 3,781,926 356,829 Feb 20 05:05 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Sale 84.22 69,948 5,890,887 286,881 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 20 '24 Sale 84.67 3,538 299,578 59,698 Feb 20 05:05 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Option Exercise 68.16 56,836 3,873,942 75,517 Feb 20 04:22 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Sale 84.02 56,836 4,775,378 18,681 Feb 20 04:22 PM Wallace Noel R. Chairman, President & CEO Feb 16 '24 Sale 84.06 29,772 2,502,664 301,343 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 16 '24 Sale 83.96 5,790 486,108 63,236 Feb 20 05:05 PM Edwards Lisa Director Feb 13 '24 Option Exercise 69.38 2,078 144,172 11,805 Feb 15 04:09 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Option Exercise 68.16 50,000 3,408,000 324,179 Feb 14 04:11 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Sale 83.15 50,000 4,157,280 274,179 Feb 14 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Option Exercise 68.16 21,023 1,432,928 26,305 Feb 13 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Sale 83.60 21,023 1,757,458 5,282 Feb 13 04:11 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Option Exercise 68.16 61,633 4,200,905 119,581 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Option Exercise 68.16 9,821 669,399 16,973 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Sale 83.93 61,633 5,172,697 57,948 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Sale 85.35 8,930 762,184 8,043 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Option Exercise 68.16 30,433 2,074,313 42,559 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Option Exercise 62.04 2,760 171,230 22,032 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Sale 84.41 30,433 2,568,706 12,126 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Sale 84.50 2,760 233,220 19,272 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Option Exercise 68.16 3,800 259,008 61,993 Dec 04 04:14 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Sale 79.01 3,800 300,219 58,193 Dec 04 04:14 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Option Exercise 68.16 15,000 1,022,400 27,371 Nov 30 04:29 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Sale 77.83 15,000 1,167,410 12,371 Nov 30 04:29 PM CAHILL JOHN T Director Nov 03 '23 Option Exercise 62.04 6,329 392,651 31,015 Nov 07 04:15 PM CAHILL JOHN T Director Nov 03 '23 Sale 74.92 6,329 474,170 24,686 Nov 07 04:15 PM Kooyman John W Chief of Staff Nov 03 '23 Sale 75.11 3,000 225,330 5,347 Nov 07 04:14 PM NORRINGTON LORRIE M Director Nov 02 '23 Option Exercise 62.04 6,329 392,651 37,636 Nov 06 04:22 PM NORRINGTON LORRIE M Director Nov 02 '23 Sale 74.56 6,329 471,919 31,307 Nov 06 04:22 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Option Exercise 73.00 48,627 3,549,771 295,596 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Option Exercise 73.00 24,704 1,803,392 77,517 Sep 13 04:05 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Sale 73.37 48,627 3,567,982 246,969 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Sale 73.31 24,704 1,811,016 52,813 Sep 13 04:05 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Option Exercise 73.00 10,493 765,989 18,345 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Sale 73.90 10,493 775,457 7,852 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 30 '23 Sale 73.85 1,365 100,805 7,852 Sep 01 04:03 PM Kooyman John W Chief of Staff Aug 02 '23 Option Exercise 73.00 21,677 1,582,421 28,061 Aug 04 04:05 PM Kooyman John W Chief of Staff Aug 02 '23 Sale 77.69 21,677 1,684,062 6,384 Aug 04 04:05 PM Daniels Jennifer CLO and Secretary May 19 '23 Option Exercise 73.00 24,703 1,803,319 77,472 May 23 04:10 PM Daniels Jennifer CLO and Secretary May 19 '23 Sale 79.70 24,703 1,968,930 52,769 May 23 04:10 PM Massey Sally Chief Human Resources Officer May 15 '23 Option Exercise 73.00 14,594 1,065,362 23,209 May 17 04:07 PM Massey Sally Chief Human Resources Officer May 15 '23 Sale 81.55 14,594 1,190,141 8,615 May 17 04:07 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Option Exercise 73.00 13,698 999,954 20,604 May 12 04:10 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Sale 81.08 13,698 1,110,579 6,906 May 12 04:10 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Sale 81.01 2,404 194,739 822 May 12 04:10 PM BILBREY JOHN P Director May 09 '23 Option Exercise 71.65 5,703 408,620 31,960 May 10 04:23 PM BILBREY JOHN P Director May 09 '23 Sale 80.81 5,703 460,869 26,257 May 10 04:23 PM Parameswaran Prabha Grp Pres, Growth & Strategy May 08 '23 Option Exercise 73.00 64,373 4,699,229 76,800 May 10 04:21 PM Wallace Noel R. Chairman, President & CEO May 08 '23 Option Exercise 73.00 50,000 3,650,000 296,619 May 10 04:21 PM Parameswaran Prabha Grp Pres, Growth & Strategy May 08 '23 Sale 80.58 64,373 5,187,170 12,427 May 10 04:21 PM Wallace Noel R. Chairman, President & CEO May 08 '23 Sale 80.66 50,000 4,032,920 246,619 May 10 04:21 PM
Index S&P 500
P/E 36.72
EPS (ttm) 15.59
Insider Own 0.18%
Shs Outstand 386.65M
Perf Week -0.21%
Market Cap 218.48B
Forward P/E 23.47
EPS next Y 24.39
Insider Trans -19.67%
Shs Float 381.04M
Perf Month 0.31%
Income 6.03B
PEG 5.54
EPS next Q 5.12
Inst Own 91.83%
Short Float 0.68%
Perf Quarter 3.73%
Sales 42.49B
P/S 5.14
EPS this Y 0.69%
Inst Trans 0.05%
Short Ratio 1.93
Perf Half Y 29.76%
Book/sh 119.24
P/B 4.80
EPS next Y 12.39%
ROA 6.29%
Short Interest 2.59M
Perf Year 3.99%
Cash/sh 19.01
P/C 30.11
EPS next 5Y 6.63%
ROE 13.75%
52W Range 415.60 - 603.82
Perf YTD 7.84%
Dividend Est. 1.50 (0.26%)
P/FCF 28.90
EPS past 5Y 16.37%
ROI 7.87%
52W High -5.21%
Beta 0.80
Dividend TTM 1.44 (0.25%)
Quick Ratio 1.33
Sales past 5Y 12.53%
Gross Margin 39.47%
52W Low 37.72%
ATR (14) 11.61
Dividend Ex-Date Mar 14, 2024
Current Ratio 1.70
EPS Y/Y TTM 1.48%
Oper. Margin 17.51%
RSI (14) 51.90
Volatility 1.85% 1.93%
Employees 122000
Debt/Eq 0.78
Sales Y/Y TTM -3.00%
Profit Margin 14.20%
Recom 1.75
Target Price 625.46
Option/Short Yes / Yes
LT Debt/Eq 0.68
EPS Q/Q 4.10%
Payout 9.06%
Rel Volume 1.30
Prev Close 571.25
Sales Surprise 1.87%
EPS Surprise 8.52%
Sales Q/Q -3.41%
Earnings Apr 24 BMO
Avg Volume 1.34M
Price 572.38
SMA20 0.91%
SMA50 -0.42%
SMA200 7.80%
Trades
Volume 1,739,023
Change 0.20%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-18-24 Resumed
Citigroup
Neutral
$620
Jan-24-24 Downgrade
Barclays
Overweight → Equal Weight
$475 → $555
Jan-08-24 Downgrade
Bernstein
Outperform → Mkt Perform
Dec-18-23 Initiated
HSBC Securities
Buy
$610
Dec-13-23 Initiated
Wolfe Research
Outperform
$575
Oct-26-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Oct-25-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$52 → $475
Sep-28-23 Initiated
Bernstein
Outperform
$603
Sep-06-23 Resumed
Citigroup
Buy
$625
Jul-19-23 Reiterated
Robert W. Baird
Outperform
$670 → $664
Jul-19-23 Initiated
Raymond James
Outperform
$595
Jul-13-23 Upgrade
Credit Suisse
Neutral → Outperform
$620
Apr-04-23 Reiterated
Barclays
Overweight
$660 → $625
Dec-14-22 Initiated
Deutsche Bank
Buy
$620
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$661
Oct-27-22 Downgrade
The Benchmark Company
Buy → Hold
Aug-25-22 Initiated
Credit Suisse
Neutral
$675
Apr-25-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$525
Jan-26-22 Resumed
Barclays
Overweight
$700
Oct-20-21 Upgrade
Citigroup
Neutral → Buy
$620 → $700
Show Previous Ratings
Today 01:02AM
May-03-24 04:21AM
May-02-24 04:49PM
May-01-24 11:24AM
10:58AM
08:00AM
Loading…
08:00AM
Apr-29-24 04:46PM
02:35PM
10:38AM
06:45AM
Apr-26-24 08:17AM
Apr-25-24 12:50PM
03:03AM
Apr-24-24 10:41PM
(Thomson Reuters StreetEvents)
02:15PM
02:15PM
Loading…
02:15PM
12:38PM
11:54AM
11:17AM
11:03AM
10:54AM
09:30AM
07:31AM
07:11AM
06:46AM
06:06AM
(Associated Press Finance)
06:05AM
06:00AM
04:01AM
Apr-23-24 06:59AM
11:09AM
Loading…
Apr-22-24 11:09AM
Apr-21-24 07:00AM
Apr-20-24 09:16AM
Apr-19-24 09:15AM
07:53AM
Apr-18-24 04:27PM
Apr-16-24 08:00AM
Apr-15-24 12:58PM
Apr-13-24 10:02AM
Apr-10-24 01:22PM
Apr-09-24 08:34AM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
Apr-02-24 06:15PM
08:36AM
08:00AM
08:00AM
Mar-28-24 02:36PM
02:10PM
02:07PM
08:01AM
Mar-27-24 06:00PM
Mar-26-24 06:15PM
08:02AM
Mar-22-24 09:41AM
Mar-21-24 10:25AM
02:53AM
Mar-20-24 06:00PM
06:29AM
Mar-19-24 08:00AM
Mar-18-24 06:15PM
Mar-17-24 05:47PM
Mar-14-24 12:00PM
09:38AM
09:00AM
Mar-12-24 06:00PM
09:09AM
Mar-11-24 03:04PM
10:20AM
Mar-06-24 06:00PM
02:45PM
(Investor's Business Daily)
Mar-05-24 06:00AM
Mar-01-24 11:30AM
09:00AM
08:00AM
Feb-29-24 09:30PM
06:00PM
03:04PM
Feb-28-24 08:00AM
Feb-26-24 01:19PM
Feb-23-24 12:02AM
Feb-21-24 05:00PM
Feb-20-24 06:00AM
Feb-19-24 10:55AM
Feb-17-24 01:29PM
Feb-15-24 04:13PM
06:11AM
Feb-14-24 10:01AM
Feb-13-24 02:41PM
Feb-10-24 10:25AM
Feb-06-24 08:43AM
08:12AM
06:01AM
Feb-02-24 11:02AM
06:19AM
Jan-31-24 10:31PM
(Thomson Reuters StreetEvents)
04:43PM
03:04PM
12:15PM
12:14PM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CASPER MARC N Chairman & CEO May 01 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 02 04:19 PM CASPER MARC N Chairman & CEO May 01 '24 Sale 573.74 10,000 5,737,356 123,816 May 02 04:19 PM CASPER MARC N Chairman & CEO Apr 30 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 30 '24 Sale 572.41 10,000 5,724,147 123,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 29 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 29 '24 Sale 575.94 10,000 5,759,384 123,816 May 01 04:35 PM Boxer Michael A SVP and General Counsel Apr 26 '24 Option Exercise 210.68 2,000 421,360 15,083 Apr 29 04:43 PM Boxer Michael A SVP and General Counsel Apr 26 '24 Sale 567.94 2,000 1,135,880 13,083 Apr 29 04:43 PM CASPER MARC N Chairman & CEO Mar 13 '24 Option Exercise 190.59 10,000 1,905,900 133,816 Mar 14 04:03 PM CASPER MARC N Chairman & CEO Mar 13 '24 Sale 594.58 10,000 5,945,759 123,816 Mar 14 04:03 PM Britt Lisa P. Sr. VP and Chief HR Officer Mar 12 '24 Option Exercise 198.85 14,345 2,852,545 25,768 Mar 13 04:31 PM CASPER MARC N Chairman & CEO Mar 12 '24 Option Exercise 190.59 10,000 1,905,900 133,816 Mar 13 05:24 PM Britt Lisa P. Sr. VP and Chief HR Officer Mar 12 '24 Sale 598.90 14,345 8,591,220 17,323 Mar 13 04:31 PM CASPER MARC N Chairman & CEO Mar 12 '24 Sale 597.98 10,000 5,979,758 123,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Mar 11 '24 Option Exercise 190.59 10,000 1,905,900 135,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Mar 11 '24 Sale 595.36 10,000 5,953,598 125,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Feb 29 '24 Option Exercise 190.59 10,000 1,905,900 135,816 Mar 04 04:36 PM CASPER MARC N Chairman & CEO Feb 29 '24 Sale 571.08 10,000 5,710,818 125,816 Mar 04 04:36 PM CASPER MARC N Chairman & CEO Feb 28 '24 Option Exercise 190.59 10,000 1,905,900 138,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 28 '24 Sale 570.18 10,000 5,701,759 128,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 27 '24 Option Exercise 190.59 10,000 1,905,900 138,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 27 '24 Sale 564.72 10,000 5,647,196 128,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 15 '24 Sale 550.62 5,547 3,054,290 43,608 Feb 20 04:51 PM Spar Debora L Director Feb 12 '24 Sale 546.97 164 89,703 1,207 Feb 14 04:36 PM Boxer Michael A SVP and General Counsel Feb 07 '24 Option Exercise 192.98 14,566 2,810,947 27,467 Feb 08 04:53 PM Boxer Michael A SVP and General Counsel Feb 07 '24 Sale 562.00 14,566 8,186,092 12,901 Feb 08 04:53 PM CASPER MARC N Chairman & CEO Feb 07 '24 Sale 555.63 10,000 5,556,287 49,155 Feb 08 04:51 PM CASPER MARC N Chairman & CEO Nov 07 '23 Option Exercise 157.68 1,600 252,288 132,775 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 07 '23 Sale 460.25 1,600 736,404 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 '23 Sale 454.41 10,000 4,544,053 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 03 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 03 '23 Sale 456.15 10,000 4,561,459 131,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 '23 Sale 445.49 10,000 4,454,880 131,175 Nov 06 04:34 PM Pettiti Gianluca Executive Vice President Aug 30 '23 Option Exercise 253.99 3,000 761,970 20,556 Aug 31 04:15 PM Pettiti Gianluca Executive Vice President Aug 30 '23 Sale 557.77 3,000 1,673,310 17,556 Aug 31 04:15 PM CASPER MARC N Chairman & CEO Aug 08 '23 Option Exercise 157.68 1,600 252,288 136,930 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 08 '23 Sale 550.60 1,600 880,960 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 '23 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 '23 Sale 551.94 10,000 5,519,370 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 04 '23 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 04 '23 Sale 550.33 10,000 5,503,317 135,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 '23 Option Exercise 157.68 10,000 1,576,800 151,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 '23 Sale 549.00 10,000 5,490,050 141,330 Aug 07 04:05 PM Williamson Stephen Sr. VP and CFO Aug 01 '23 Option Exercise 190.59 14,100 2,687,319 41,493 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Aug 01 '23 Sale 550.00 14,100 7,755,000 27,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 '23 Option Exercise 190.59 15,000 2,858,850 42,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 '23 Sale 557.42 15,000 8,361,300 27,393 Aug 02 04:33 PM Boxer Michael A SVP and General Counsel Jun 26 '23 Buy 526.15 4 2,105 13,101 Oct 06 04:23 PM CASPER MARC N Chairman & CEO May 09 '23 Option Exercise 157.68 1,600 252,288 142,930 May 10 04:13 PM CASPER MARC N Chairman & CEO May 09 '23 Sale 534.82 1,600 855,710 141,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 08 '23 Option Exercise 157.68 10,000 1,576,800 151,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 08 '23 Sale 544.40 10,000 5,444,003 141,330 May 10 04:13 PM CASPER MARC N Chairman & CEO May 05 '23 Option Exercise 157.68 10,000 1,576,800 151,330 May 08 04:21 PM CASPER MARC N Chairman & CEO May 05 '23 Sale 545.22 10,000 5,452,236 141,330 May 08 04:21 PM
Index RUT
P/E -
EPS (ttm) -0.14
Insider Own 58.66%
Shs Outstand 648.32M
Perf Week 13.69%
Market Cap 429.06M
Forward P/E -
EPS next Y -0.14
Insider Trans 0.00%
Shs Float 271.10M
Perf Month -20.76%
Income -91.70M
PEG -
EPS next Q -0.05
Inst Own 36.01%
Short Float 6.17%
Perf Quarter -36.48%
Sales 961.52M
P/S 0.45
EPS this Y -37.86%
Inst Trans -5.19%
Short Ratio 8.59
Perf Half Y -60.10%
Book/sh 2.64
P/B 0.25
EPS next Y 27.71%
ROA -1.26%
Short Interest 16.74M
Perf Year -21.62%
Cash/sh 0.12
P/C 5.27
EPS next 5Y 22.80%
ROE -5.24%
52W Range 0.53 - 2.29
Perf YTD -54.56%
Dividend Est. -
P/FCF 6.82
EPS past 5Y -
ROI -1.47%
52W High -71.43%
Beta 0.82
Dividend TTM -
Quick Ratio 1.16
Sales past 5Y -1.06%
Gross Margin 31.83%
52W Low 23.45%
ATR (14) 0.07
Dividend Ex-Date -
Current Ratio 1.16
EPS Y/Y TTM 84.16%
Oper. Margin 18.03%
RSI (14) 42.39
Volatility 9.51% 10.29%
Employees 2800
Debt/Eq 2.67
Sales Y/Y TTM -10.95%
Profit Margin -9.54%
Recom 2.00
Target Price 1.68
Option/Short Yes / Yes
LT Debt/Eq 2.66
EPS Q/Q 95.24%
Payout -
Rel Volume 0.37
Prev Close 0.67
Sales Surprise -1.19%
EPS Surprise 26.61%
Sales Q/Q 1.26%
Earnings May 08 BMO
Avg Volume 1.95M
Price 0.65
SMA20 -6.46%
SMA50 -20.53%
SMA200 -51.76%
Trades
Volume 713,195
Change -1.71%
Index RUT
P/E -
EPS (ttm) -0.14
Insider Own 74.45%
Shs Outstand 135.35M
Perf Week 0.50%
Market Cap 1.37B
Forward P/E 15.95
EPS next Y 0.63
Insider Trans -0.13%
Shs Float 34.74M
Perf Month 1.00%
Income -19.43M
PEG -
EPS next Q 0.16
Inst Own 26.76%
Short Float 3.13%
Perf Quarter 39.50%
Sales 1.17B
P/S 1.17
EPS this Y 5.88%
Inst Trans 0.06%
Short Ratio 0.57
Perf Half Y 81.33%
Book/sh 6.95
P/B 1.45
EPS next Y 8.74%
ROA -0.78%
Short Interest 1.09M
Perf Year -38.38%
Cash/sh 0.15
P/C 68.52
EPS next 5Y -
ROE -2.06%
52W Range 5.07 - 18.61
Perf YTD 27.53%
Dividend Est. -
P/FCF 16.45
EPS past 5Y 10.72%
ROI -0.94%
52W High -45.73%
Beta -
Dividend TTM -
Quick Ratio 1.34
Sales past 5Y 16.32%
Gross Margin 34.40%
52W Low 99.21%
ATR (14) 0.08
Dividend Ex-Date Nov 15, 2019
Current Ratio 1.72
EPS Y/Y TTM -162.71%
Oper. Margin 5.90%
RSI (14) 60.08
Volatility 0.97% 0.61%
Employees 5800
Debt/Eq 1.24
Sales Y/Y TTM 4.75%
Profit Margin -1.65%
Recom 3.00
Target Price 10.00
Option/Short Yes / Yes
LT Debt/Eq 1.20
EPS Q/Q -274.79%
Payout -
Rel Volume 2.08
Prev Close 10.06
Sales Surprise -0.14%
EPS Surprise 9.43%
Sales Q/Q 3.66%
Earnings Mar 05 AMC
Avg Volume 1.91M
Price 10.10
SMA20 0.43%
SMA50 1.80%
SMA200 14.56%
Trades
Volume 3,975,035
Change 0.40%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Downgrade
UBS
Buy → Neutral
$10
Feb-06-24 Initiated
KeyBanc Capital Markets
Sector Weight
Jan-04-24 Initiated
Craig Hallum
Buy
$23
Nov-14-23 Upgrade
UBS
Neutral → Buy
$16 → $10
Sep-05-23 Downgrade
BofA Securities
Neutral → Underperform
$18 → $11
Aug-24-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$15 → $10
Aug-15-23 Downgrade
Citigroup
Buy → Neutral
$20 → $13
Aug-10-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jan-06-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Dec-16-22 Downgrade
BofA Securities
Buy → Neutral
$19
Jan-10-22 Resumed
Citigroup
Buy
$27 → $28
May-18-21 Initiated
UBS
Neutral
$16
May-18-21 Initiated
Raymond James
Outperform
$16.50
May-18-21 Initiated
Morgan Stanley
Overweight
$21
May-18-21 Initiated
KeyBanc Capital Markets
Overweight
$21
May-18-21 Initiated
Jefferies
Buy
$20
May-18-21 Initiated
Goldman
Buy
$43
May-18-21 Initiated
Citigroup
Buy
$19
May-18-21 Initiated
BofA Securities
Buy
$18
May-18-21 Initiated
BMO Capital Markets
Outperform
$18
Show Previous Ratings
Apr-30-24 05:38PM
Apr-24-24 02:00AM
Mar-27-24 04:37PM
Mar-26-24 01:19AM
Mar-20-24 03:00AM
04:41PM
Loading…
Mar-18-24 04:41PM
Mar-07-24 01:27PM
Mar-06-24 12:00PM
Mar-05-24 09:52PM
05:35PM
04:48PM
(Associated Press Finance)
04:05PM
Feb-27-24 10:00AM
08:26AM
Feb-26-24 03:44PM
01:53PM
Loading…
01:53PM
12:34PM
08:07AM
08:00AM
06:40AM
Feb-22-24 02:00AM
Feb-14-24 08:00AM
Jan-16-24 02:00AM
Jan-13-24 03:02AM
Dec-18-23 02:00AM
Nov-18-23 07:03AM
Nov-12-23 09:42AM
Nov-08-23 07:51AM
(Thomson Reuters StreetEvents) +12.93%
Nov-07-23 07:30PM
05:24PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Oct-27-23 05:03AM
Oct-19-23 07:35AM
Oct-18-23 08:00AM
Oct-06-23 04:58PM
Oct-02-23 08:00AM
Sep-22-23 05:01AM
Sep-11-23 11:21AM
Sep-08-23 03:58PM
Sep-06-23 02:00AM
Sep-05-23 08:00AM
Sep-04-23 12:17PM
Aug-21-23 04:05PM
Aug-16-23 02:43AM
Aug-11-23 06:07AM
Aug-09-23 12:39PM
(Thomson Reuters StreetEvents) -27.95%
Aug-08-23 09:30PM
05:50PM
04:54PM
04:05PM
Aug-03-23 05:35PM
Jul-18-23 05:09PM
08:00AM
Jul-13-23 08:50AM
Jun-29-23 06:56AM
Jun-21-23 08:00PM
Jun-15-23 06:28AM
Jun-09-23 08:00AM
Jun-05-23 08:46AM
May-29-23 06:47AM
May-11-23 06:09AM
May-10-23 12:23PM
(Thomson Reuters StreetEvents)
May-09-23 07:25PM
06:17PM
04:05PM
May-08-23 05:45PM
May-07-23 10:22AM
May-03-23 08:00AM
Apr-26-23 08:00PM
Apr-23-23 08:43AM
Apr-18-23 08:00AM
Mar-15-23 08:00AM
Mar-08-23 02:22PM
(Thomson Reuters StreetEvents) -7.13%
Mar-07-23 05:35PM
04:05PM
Feb-14-23 08:00AM
Jan-12-23 11:02AM
Jan-09-23 04:03PM
(American City Business Journals)
08:00AM
Dec-02-22 07:37PM
Nov-21-22 02:37PM
Nov-10-22 05:45PM
04:05PM
Nov-08-22 07:35PM
Nov-03-22 10:00AM
Oct-27-22 08:00AM
Sep-29-22 08:30AM
Aug-10-22 12:01AM
Aug-09-22 06:45PM
05:00PM
(Thomson Reuters StreetEvents)
04:05PM
Aug-04-22 07:35AM
Jul-20-22 07:15AM
Jul-19-22 08:00AM
Jun-20-22 05:09AM
May-10-22 06:45PM
04:05PM
May-06-22 08:00AM
May-03-22 03:00PM
Apr-19-22 08:00AM
Agiliti, Inc. engages in manufacturing, management, maintenance, and mobilization of mission-critical, regulated, reusable medical devices. It also offers comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes. The company was founded in 1939 and is headquartered in Eden Prairie, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Neumann Lee M EVP & GC Apr 09 '24 Sale 10.04 4,685 47,037 29,929 Apr 10 08:00 PM Neumann Lee M EVP & GC Mar 20 '24 Sale 10.07 4,685 47,178 34,614 Mar 22 08:30 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Feb 14 '24 Option Exercise 2.13 55,116 117,397 1,993,932 Feb 16 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Feb 14 '24 Sale 7.23 27,558 199,134 1,966,374 Feb 16 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Jan 11 '24 Option Exercise 2.13 55,116 117,397 1,966,374 Jan 12 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Jan 11 '24 Sale 7.31 27,558 201,449 1,938,816 Jan 12 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Dec 14 '23 Option Exercise 2.13 55,116 117,397 2,009,374 Dec 18 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Dec 14 '23 Sale 7.95 27,558 218,948 1,981,816 Dec 18 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Nov 16 '23 Option Exercise 2.13 55,116 117,397 1,981,816 Nov 17 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Nov 16 '23 Sale 7.34 27,558 202,331 1,954,258 Nov 17 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Nov 15 '23 Sale 7.52 15,000 112,785 1,926,700 Nov 17 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Oct 24 '23 Option Exercise 2.13 55,116 117,397 1,969,258 Oct 26 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Oct 24 '23 Sale 5.41 27,558 149,089 1,941,700 Oct 26 08:00 PM Leonard Thomas J CHIEF EXECUTIVE OFFICER Oct 17 '23 Sale 5.40 15,000 81,030 1,914,142 Oct 26 08:00 PM Leonard Thomas J Director Sep 20 '23 Option Exercise 2.13 55,116 117,397 993,680 Sep 21 07:30 PM Leonard Thomas J Director Sep 20 '23 Sale 7.12 27,558 196,103 966,122 Sep 21 07:30 PM Leonard Thomas J Director Sep 19 '23 Sale 7.26 15,000 108,960 938,564 Sep 21 07:30 PM Leonard Thomas J Director Aug 16 '23 Option Exercise 2.13 55,116 117,397 981,122 Aug 17 08:00 PM Leonard Thomas J Director Aug 16 '23 Sale 10.53 27,558 290,158 953,564 Aug 17 08:00 PM Leonard Thomas J Director Aug 15 '23 Sale 11.16 15,000 167,370 926,006 Aug 17 08:00 PM Pekarek James B EVP & CFO Aug 04 '23 Sale 17.05 13,823 235,655 165,248 Aug 08 09:00 PM Pekarek James B EVP & CFO Aug 02 '23 Sale 17.12 15,000 256,815 179,071 Aug 04 07:00 PM Pekarek James B EVP & CFO Jul 20 '23 Sale 16.43 10,000 164,310 194,071 Jul 24 07:00 PM Leonard Thomas J Director Jul 13 '23 Option Exercise 2.13 55,116 117,397 968,564 Jul 14 07:05 PM Leonard Thomas J Director Jul 13 '23 Sale 16.09 27,558 443,381 941,006 Jul 14 07:05 PM Leonard Thomas J Director Jul 12 '23 Sale 16.46 15,000 246,960 913,448 Jul 14 07:05 PM Pekarek James B EVP & CFO Jul 07 '23 Sale 16.14 15,000 242,055 204,071 Jul 11 07:00 PM Leonard Thomas J Director Jun 15 '23 Option Exercise 2.13 55,116 117,397 928,448 Jun 16 07:35 PM Leonard Thomas J Director Jun 15 '23 Sale 17.27 27,558 476,064 900,890 Jun 16 07:35 PM MCCABE MATTHEW E. SVP OF FINANCE & TREASURER Jun 14 '23 Option Exercise 6.27 30,000 188,100 56,091 Jun 16 07:15 PM MCCABE MATTHEW E. SVP OF FINANCE & TREASURER Jun 14 '23 Sale 18.51 35,000 647,776 26,091 Jun 16 07:15 PM Leonard Thomas J Director Jun 14 '23 Sale 17.99 15,000 269,822 900,890 Jun 16 07:35 PM Neumann Lee M EVP & GC Jun 14 '23 Sale 18.20 5,000 90,995 33,647 Jun 16 07:00 PM Pekarek James B EVP & CFO Jun 13 '23 Sale 18.26 30,000 547,860 219,071 Jun 15 07:15 PM Creviston Robert L EVP, HUMAN RESOURCES Jun 13 '23 Sale 18.39 17,000 312,562 54,515 Jun 15 07:00 PM Pekarek James B EVP & CFO May 15 '23 Option Exercise 2.13 35,920 76,510 284,991 May 16 08:30 PM Pekarek James B EVP & CFO May 15 '23 Sale 16.08 35,920 577,701 249,071 May 16 08:30 PM Pekarek James B EVP & CFO May 12 '23 Option Exercise 2.13 35,000 74,550 284,071 May 16 08:30 PM Pekarek James B EVP & CFO May 12 '23 Sale 15.87 35,000 555,548 249,071 May 16 08:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite